Article
AbbVie scopes out $60M upfront investment in glaucoma devicemaker, plus $475M buyout option
Rating:
0.0
Views:
97
Likes:
1
Library:
1
AbbVie has set its sights on a new medical device partnership to expand the scope of its existing eye-care portfolio. | AbbVie has set its sights on a new medical device partnership to expand the scope of its existing eye care portfolio.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value